Radiation Therapy and Grade II/III Oligodendroglial Tumors

Overview

Journal CNS Oncol

Specialty Oncology

Date 2015 Oct 20

PMID 26477980

Citations 3

Authors

Caroline Chung

Normand Laperriere

Affiliations

Soon will be listed here.

Abstract

Radiotherapy has been a longstanding treatment option for low-grade glioma. Improvements in tumor control and radiation-related toxicity may be attributed to advances in neuroimaging as well as radiotherapy planning and delivery. The discovery of various molecular prognostic factors have aided in patient selection for radiotherapy. These prognostic and predictive factors may also play a key role in determining which patients are likely to benefit most from combined systemic therapy and radiation.

Citing Articles

Variability in radiotherapy outcomes across cancer types: a comparative study of glioblastoma multiforme and low-grade gliomas.

Veviorskiy A, Mkrtchyan G, Osipov A, Izumchenko E, Ozerov I, Aliper A Aging (Albany NY). 2025; 17(2):550-562.

PMID: 40015963 PMC: 11892922. DOI: 10.18632/aging.206212.

An expanded role for surgery in grade 3 1p/19q co-deleted oligodendroglioma.

Gupta S, Nawabi N, Emani S, Medeiros L, Bernstock J, Duvall J Neurooncol Adv. 2023; 5(1):vdad046.

PMID: 37215951 PMC: 10195195. DOI: 10.1093/noajnl/vdad046.

Spatial metabolic heterogeneity of oligodendrogliomas at single-cell resolution.

Batchu S, Diaz M, Kleinberg G, Lucke-Wold B Brain Tumor Pathol. 2023; 40(2):101-108.

PMID: 37041322 DOI: 10.1007/s10014-023-00455-8.

Cognitive and brain structural changes in long-term oligodendroglial tumor survivors.

Cayuela N, Jaramillo-Jimenez E, Camara E, Majos C, Vidal N, Lucas A Neuro Oncol. 2019; 21(11):1470-1479.

PMID: 31549152 PMC: 6827827. DOI: 10.1093/neuonc/noz130.

References

Cairncross G, Wang M, Shaw E, Jenkins R, Brachman D, Buckner J . Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. J Clin Oncol. 2012; 31(3):337-43. PMC: 3732012. DOI: 10.1200/JCO.2012.43.2674. View

Jeremic B, Shibamoto Y, Grujicic D, Milicic B, Stojanovic M, Nikolic N . Hyperfractionated radiation therapy for incompletely resected supratentorial low-grade glioma. A phase II study. Radiother Oncol. 1999; 49(1):49-54. DOI: 10.1016/s0167-8140(98)00074-7. View

Pouratian N, Schiff D . Management of low-grade glioma. Curr Neurol Neurosci Rep. 2010; 10(3):224-31. PMC: 2857752. DOI: 10.1007/s11910-010-0105-7. View

. Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trial. J Clin Oncol. 2001; 19(2):509-18. DOI: 10.1200/JCO.2001.19.2.509. View

PRADOS M, Scott C, Curran Jr W, Nelson D, Leibel S, Kramer S . Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma: A retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapy. J Clin Oncol. 1999; 17(11):3389-95. DOI: 10.1200/JCO.1999.17.11.3389. View

Shaw E, Wang M, Coons S, Brachman D, Buckner J, Stelzer K . Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: initial results of RTOG 9802. J Clin Oncol. 2012; 30(25):3065-70. PMC: 3732006. DOI: 10.1200/JCO.2011.35.8598. View

Shaw E, Arusell R, Scheithauer B, OFallon J, ONeill B, Dinapoli R . Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol. 2002; 20(9):2267-76. DOI: 10.1200/JCO.2002.09.126. View

Buckner J, Gesme Jr D, OFallon J, Hammack J, Stafford S, Brown P . Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities. J Clin Oncol. 2003; 21(2):251-5. DOI: 10.1200/JCO.2003.06.023. View

Viaccoz A, Lekoubou A, Ducray F . Chemotherapy in low-grade gliomas. Curr Opin Oncol. 2012; 24(6):694-701. DOI: 10.1097/CCO.0b013e328357f503. View

10.

van den Bent M, Taphoorn M, Brandes A, Menten J, Stupp R, Frenay M . Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971. J Clin Oncol. 2003; 21(13):2525-8. DOI: 10.1200/JCO.2003.12.015. View

11.

Karim A, Maat B, Hatlevoll R, Menten J, Rutten E, Thomas D . A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys. 1996; 36(3):549-56. DOI: 10.1016/s0360-3016(96)00352-5. View

12.

Quinn J, Reardon D, Friedman A, Rich J, Sampson J, Provenzale J . Phase II trial of temozolomide in patients with progressive low-grade glioma. J Clin Oncol. 2003; 21(4):646-51. DOI: 10.1200/JCO.2003.01.009. View

13.

Cairncross G, Berkey B, Shaw E, Jenkins R, Scheithauer B, Brachman D . Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. J Clin Oncol. 2006; 24(18):2707-14. DOI: 10.1200/JCO.2005.04.3414. View

14.

Wick W, Hartmann C, Engel C, Stoffels M, Felsberg J, Stockhammer F . NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. J Clin Oncol. 2009; 27(35):5874-80. DOI: 10.1200/JCO.2009.23.6497. View

15.

Eyre H, Crowley J, Townsend J, Eltringham J, Morantz R, Schulman S . A randomized trial of radiotherapy versus radiotherapy plus CCNU for incompletely resected low-grade gliomas: a Southwest Oncology Group study. J Neurosurg. 1993; 78(6):909-14. DOI: 10.3171/jns.1993.78.6.0909. View

16.

Brada M, Stenning S, Gabe R, Thompson L, Levy D, Rampling R . Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade glioma. J Clin Oncol. 2010; 28(30):4601-8. DOI: 10.1200/JCO.2009.27.1932. View

17.

van den Bent M, Afra D, De Witte O, Ben Hassel M, Schraub S, Hoang-Xuan K . Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet. 2005; 366(9490):985-90. DOI: 10.1016/S0140-6736(05)67070-5. View

18.

Fine H, Dear K, Loeffler J, Black P, Canellos G . Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer. 1993; 71(8):2585-97. DOI: 10.1002/1097-0142(19930415)71:8<2585::aid-cncr2820710825>3.0.co;2-s. View

19.

van den Bent M, Brandes A, Taphoorn M, Kros J, Kouwenhoven M, Delattre J . Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. J Clin Oncol. 2012; 31(3):344-50. DOI: 10.1200/JCO.2012.43.2229. View

20.

Kesari S, Schiff D, Drappatz J, LaFrankie D, Doherty L, Macklin E . Phase II study of protracted daily temozolomide for low-grade gliomas in adults. Clin Cancer Res. 2009; 15(1):330-7. DOI: 10.1158/1078-0432.CCR-08-0888. View